Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

Xenetic, Excivion to develop Zika vaccine

Since news broke that the Zika virus, which has been plaguing parts of South America and Puerto Rico, has spread to Florida, the urgency for prevention tactics have increased in the U.S.

Nashville Healthcare IT companies attracting venture capitalists

Nashville healthcare IT companies are booming this year and quickly becoming the most popular sector of healthcare in the city among venture capitalists, according to new research.

Spreemo names new leadership as it continues executive-level expansion

Healthcare analytics company Spreemo has continued its executive-level this week, only a week after naming a new president and COO.

Johnson & Johnson loses battle on rheumatoid arthritis drug patent

A federal judge told drug maker Johnson & Johnson it will not get to hold onto its patent for the rheumatoid arthritis drug Remicade. 

ProclaRx names Doug Martin COO

Biotechnology company ProclaRx named a new chief operation officer today as it switches up its executive team.

Sasmar Pharmaceuticals acquires Chicago-based Aquatrove

Sasmar Pharmaceuticals, a Belgium-based pharmaceutical manufacturer, has acquired Aquatrove Biosciences this week as it continues to expand its portfolio of biotechnology companies that will help improve its product pipeline.

New cholesterol medication can save lives, but costs remain considerable

The FDA recently approved a cholesterol-lowering drug capable of preventing significant amounts of deaths, nonfatal MI and strokes. Unfortunately, most patients can’t afford it.  

Midwest healthcare startups raise more than $1 billion in first half of 2016

Midwest healthcare startups are booming so far this year, according to a new report from Cleveland-based BioEnterprise.

Displaying 1881 - 1888 of 3249

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.